Skip to main content
Back
Watch Compare

BIOHARVEST SCIENCES INC.

Data quality: 83%
BHST
NASDAQ Manufacturing Chemicals
$4.31
▼ $0.01 (-0.12%)
Mkt Cap: 97.93 M
Price
$4.32
Mkt Cap
97.93 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Debt/Equity of 0.01 — conservative balance sheet
Negative free cash flow of -9.58 M
Capital efficient — spends only 6.82% of revenue on capex

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)37.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-83.17%
Below sector avg (-54.01%)
ROICN/A
Net Margin-32.27%
Op. Margin-16.16%

Safety

Debt / Equity
0.01
Below sector avg (0.30)
Current Ratio3.97
Interest CoverageN/A

Valuation

PE (TTM|NTM)
-8.79 | -107.75
Below sector avg (-1.49)
P/B Ratio3.85
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1385 peers)
Metric Stock Sector Median
P/E -8.8 -1.5
P/B 3.9 1.6
ROE % -83.2 -54.0
Net Margin % -32.3 -41.5
Rev Growth 5Y % — 1.8
D/E 0.0 0.3

Analyst Price Target

4 analysts
Buy
Current
$4.31
+196.2%
Target
$12.75
$10.00
$13.00
$15.00
Forecast
Forward P/E -107.75
Forward EPS -$0.04
Est. Revenue 61.15 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$0.04
-$0.25 – $0.22
 61.15 M 4
FY2026 -$0.35
-$0.45 – -$0.28
 44.17 M 3

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.11 -$0.10 +4.8%
Q32025 -$0.12 -$0.14 -21.7%
Q22025 -$0.11 -$0.24 -123.3%
Q12025 -$0.12 -$0.13 -8.3%

All Fundamental Metrics
Growth
Revenue Growth (1Y) 37.00% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 34.51 M Net Income (TTM) -11.14 M
ROE -83.17% ROA N/A
Gross Margin N/A Operating Margin -16.16%
Net Margin -32.27% Free Cash Flow (TTM) -9.58 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity 0.01 Current Ratio 3.97
Interest Coverage N/A Asset Turnover N/A
Working Capital 22.82 M Tangible Book Value 25.45 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -8.79 Forward P/E -107.75
P/B Ratio 3.85 P/S Ratio 2.84
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 1.60 Fwd Earnings Yield N/A
FCF Yield -9.78%
Market Cap 97.93 M Enterprise Value 75.05 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 1.52
FCF / Share -0.42 OCF / Share -0.32
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 6.82% FCF Conversion 86.04%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024
Revenue 34.51 M 25.19 M
Net Income -11.14 M -12.91 M
EPS (Diluted) — —
Gross Profit — —
Operating Income -5.58 M -6.99 M
EBITDA — —
R&D Expenses — —
SG&A Expenses — —
D&A 1.62 M 1.25 M
Interest Expense — —
Income Tax -76,000.0 8,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024
Total Assets — —
Total Liabilities — —
Shareholders' Equity 25.45 M 1.33 M
Total Debt 149,000.0 3.91 M
Cash & Equivalents 23.03 M 2.39 M
Current Assets 30.50 M 7.86 M
Current Liabilities 7.68 M 14.26 M